|
Volumn 124, Issue 9, 2004, Pages 599-604
|
Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by rhG-CSF in patients receiving antineoplastic drugs
|
Author keywords
Chemotherapy; Dosage regimen; Granulocyte colony stimulating factor; Neutrophil; Pharmacodynamic model
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
DOXORUBICIN;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
CISPLATIN;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CELL COUNT;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG INHIBITION;
FEMALE;
HUMAN;
LUNG CANCER;
NEUTROPHIL;
OVARY CANCER;
PREDICTION;
BIOLOGICAL MODEL;
BLOOD;
LEUKOCYTE COUNT;
LUNG TUMOR;
METHODOLOGY;
OVARY TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CISPLATIN;
DOXORUBICIN;
FEMALE;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
HUMANS;
LEUKOCYTE COUNT;
LUNG NEOPLASMS;
MODELS, BIOLOGICAL;
NEUTROPHILS;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
EID: 7444225908
PISSN: 00316903
EISSN: None
Source Type: Journal
DOI: 10.1248/yakushi.124.599 Document Type: Article |
Times cited : (3)
|
References (15)
|